Schedule 13D ownership disclosure
HedgePath Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 42278K102
Event date: 2014-06-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 51.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-14-266554
- Form type
- SC 13D
- Filer
- Inhibitor Therapeutics, Inc.
- CIK
- CIK 1042418
- Filed
- Jul 11, 2014
- Reporting period
- Jun 24, 2014
- Description
- Schedule 13D beneficial ownership